Search for Clinical Trial Results

Sponsored By

Lymphoma, T-Cell, Peripheral - 25 Studies Found

Status Study
Not yet recruiting Study Name: 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma
Condition: Lymphoma, T-Cell, Peripheral
Date: 2017-02-09
Interventions: Device: 18F-FDG PET/ CT 18F-FDG PET/CT will be conducted before, during and after chemotherapy. Patients
Not yet recruiting Study Name: Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma
Condition: Lymphoma, T-Cell, Peripheral
Date: 2017-02-09
Interventions: Device: 18F-FDG PET/CT 18F-FDG PET/CT will be conducted before, during and after chemotherapy. Patients
Recruiting Study Name: T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma
Condition: Lymphoma, T-Cell, Peripheral
Date: 2010-06-10
Recruiting Study Name: A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
Condition: Lymphoma, T-Cell, Peripheral
Date: 2005-09-13
Interventions: Drug: ONTAK (denileukin diftitox, DAB389 IL-2) Ontak + CHOP every 3 weeks.
Completed Study Name: Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma
Condition: Lymphoma, T-Cell, Peripheral
Date: 2012-08-30
Interventions:
  • Procedure: Clin A. CHOP-CAMPATH (Chemo-immunotherapy) + SCT

Completed Study Name: A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas
Condition: Lymphoma, T-Cell, Peripheral
Date: 2016-05-23
Interventions: Other: No Intervention
Active, not recruiting Study Name: A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL)
Condition: Lymphoma, T-cell, Peripheral
Date: 2011-10-18
Interventions: Drug: Romidepsin Intravenous dosing for 4 hours on Days 1, 8, and 15 of each 28-day cycle
Not yet recruiting Study Name: Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients
Condition: Peripheral T Cell Lymphoma
Date: 2016-11-03
Interventions:
  • Drug: chidamide 30mg po twice

Recruiting Study Name: Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study
Condition: Peripheral T-cell Lymphomas
Date: 2015-07-26
Interventions:
  • Drug: GDP GDP is a a combinati
Completed Study Name: Treatment of Peripheral T-cell Lymphoma
Condition: Peripheral T-cell Lymphoma
Date: 2012-08-10
Interventions:
  • Drug: GDPT regimen GDPT regime
Next >>>